The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2017
Filed:
Aug. 25, 2014
Applicant:
Thomas Luger, Muenster, DE;
Inventor:
Thomas Luger, Muenster, DE;
Assignee:
Other;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/18 (2016.01); C07K 5/09 (2006.01); A61K 31/198 (2006.01); A61K 38/04 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); A61K 39/00 (2006.01); C07K 5/068 (2006.01);
U.S. Cl.
CPC ...
C07K 5/0815 (2013.01); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A61K 31/198 (2013.01); A61K 38/04 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 39/001 (2013.01); C07K 5/06086 (2013.01); A61K 2039/5154 (2013.01); C12N 2501/86 (2013.01);
Abstract
The present invention relates to the use of compounds selected from the group consisting of Lys-(D)Pro-Thr, N-acyl Lys-(D)Pro-Thr, C-amide Lys-(D)Pro-Thr, and C-esters of Lys-(D)Pro-Thr; or a pharmaceutically acceptable salt of said compound for the treatment of inflammatory disorders. The invention also relates to the use of αMSH for inducing tolerance.